Investment Firm
Overview
Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications.
Jan 01, 2002
Seed
Highlights
Location
Social
N/A
Investor Lead
Participant Investors
5
Prodesse raised $1500000 on 2002-01-01 in Seed Round
Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications.
Company Funding History
1
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jan 01, 2002 | Seed Round - Prodesse | 5 | - | 1.5M |
Recent Activity
There is no recent news or activity for this profile.